Tìm theo
VPM4001
Thuốc Gốc
Biotech
VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells.
Chỉ Định : Investigated for use/treatment in prostate cancer.
Tài Liệu Tham Khảo Thêm
... loading
... loading